Product
Pantoprazole
9 clinical trials
19 indications
Indication
Gastroesophageal Reflux DiseaseIndication
EsophagitisIndication
Prevention & ControlIndication
Acute Kidney InjuryIndication
Pancreatic CancerIndication
Ampullary CancerIndication
Pancreatic Neuroendocrine TumorIndication
PancreatitisIndication
CholangiocarcinomaIndication
Duodenal CancerIndication
Functional DyspepsiaIndication
Childhood ObesityIndication
NAFLDIndication
Gastroesophageal reflux diseaseIndication
Antiplatelet TherapyIndication
Coronary Artery BypassIndication
Gastrointestinal HemorrhageIndication
UpperClinical trial
AN OPEN-LABEL, MULTICENTER STUDY TO EVALUATE THE PHARMACOKINETICS OF SINGLE AND MULTIPLE INTRAVENOUS DOSES OF PANTOPRAZOLE IN TWO AGE COHORTS OF HOSPITALIZED PEDIATRIC SUBJECTS 1 TO 16 YEARS OF AGE WHO ARE CANDIDATES FOR ACID SUPPRESSION THERAPYStatus: Terminated, Estimated PCD: 2021-06-18
Clinical trial
AN EXPLORATORY, MULTICENTER, RANDOMIZED, DOUBLE BLIND STUDY OF CLINICAL OUTCOMES, TOLERABILITY, AND SAFETY OF 2 DOSES OF ORAL PANTOPRAZOLE IN PEDIATRIC PARTICIPANTS AGED 1 TO 11 YEARS AND 12 TO 17 YEARS WHO REQUIRE MAINTENANCE THERAPY FOR HEALED EROSIVE ESOPHAGITISStatus: Recruiting, Estimated PCD: 2027-12-09
Clinical trial
A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS).Status: Completed, Estimated PCD: 2017-07-21
Clinical trial
Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump Inhibitor: A Prospective Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Evaluation of the Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyStatus: Active (not recruiting), Estimated PCD: 2024-06-30
Clinical trial
Duodenal Neuro-immune Interactions and Effects of PPI in Functional DyspepsiaStatus: Recruiting, Estimated PCD: 2024-01-31
Clinical trial
Physiologic Determinants of PPI Disposition in ChildrenStatus: Recruiting, Estimated PCD: 2024-12-31
Clinical trial
Evaluation of the Efficacy of Different Duration of a Proton Pump Inhibitor in the Prevention of Upper Gastrointestinal Mucosal Injury in Patients Taking 12-month Dual Antiplatelet Therapy After Coronary Artery Bypass GraftingStatus: Active (not recruiting), Estimated PCD: 2023-12-30
Clinical trial
Re-EValuating the Inhibition of Stress Erosions: Prophylaxis Against Gastrointestinal Bleeding in the Critically Ill (The REVISE) TrialStatus: Completed, Estimated PCD: 2023-10-31